6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: March 15, 2018
Period of Report: March 15, 2018
Accession Number: 0001157523-18-000566

View Document ↗ View on SEC.gov ↗